FIBRINOGEN - IS BENEFIT WORTH RISK

被引：31
作者：
BOVE, JR
机构：
来源：
TRANSFUSION | 1978年 / 18卷 / 02期
关键词：
D O I：
10.1046/j.1537-2995.1978.18278160573.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：129 / 136
页数：8
相关论文
共 57 条
[1]   COMPLICATIONS DURING FIBRINOGEN THERAPY IN CASE OF ABRUPTIO PLACENTAE [J].
ALBRECHTSEN, OK ;
SKJODT, P .
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1964, 43 (02) :129-&
[2]   CLINICAL USE OF DRIED FIBRINOGEN (HUMAN) AND RISK OF TRANSMITTING HEPATITIS BY ITS ADMINISTRATION [J].
ANDERSON, HD ;
MCCALL, KB ;
SGOURIS, JT ;
GIBSON, ST .
TRANSFUSION, 1966, 6 (03) :234-&
[3]  
BACHMANN F, 1971, Hospital Practice, V6, P113
[4]  
Barker L F, 1974, Dev Biol Stand, V27, P178
[5]  
BICK RL, 1976, TRANSFUSION, V16, P361
[6]  
BLOMBACK B, 1956, ARK KEMI, V10, P415
[7]  
BRITTIN GM, 1972, AM J CLIN PATHOL, V57, P89
[8]  
CLAUSS A., 1957, ACTA HAEMATOL, V17, P237
[9]   PREPARATION AND PROPERTIES OF SERUM AND PLASMA PROTEINS .4. A SYSTEM FOR THE SEPARATION INTO FRACTIONS OF THE PROTEIN AND LIPOPROTEIN COMPONENTS OF BIOLOGICAL TISSUES AND FLUIDS [J].
COHN, EJ ;
STRONG, LE ;
HUGHES, WL ;
MULFORD, DJ ;
ASHWORTH, JN ;
MELIN, M ;
TAYLOR, HL .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1946, 68 (03) :459-475
[10]  
ELLIS BC, 1961, J LAB CLIN MED, V58, P477
123456